ArticleUnited European gastroenterology journal2026
Cohort Study: Risk of Gallstones and Biliary Complications With Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes.
Mohamed H Eldesouki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.